1. Home
  2. AZN vs WFC Comparison

AZN vs WFC Comparison

Compare AZN & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

SELL

Current Price

$183.94

Market Cap

286.0B

Sector

Health Care

ML Signal

SELL

Logo Wells Fargo & Company

WFC

Wells Fargo & Company

SELL

Current Price

$84.61

Market Cap

258.3B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
AZN
WFC
Founded
1992
1852
Country
United Kingdom
United States
Employees
N/A
194369
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
286.0B
258.3B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
AZN
WFC
Price
$183.94
$84.61
Analyst Decision
Buy
Buy
Analyst Count
12
27
Target Price
★ $208.08
$97.38
AVG Volume (30 Days)
2.8M
★ 8.5M
Earning Date
10-30-2026
10-13-2026
Dividend Yield
1.75%
★ 2.32%
EPS Growth
N/A
★ 16.57
EPS
N/A
★ 5.47
Revenue
N/A
★ $85,063,000,000.00
Revenue This Year
$7.90
$5.36
Revenue Next Year
$6.38
$5.34
P/E Ratio
$31.91
★ $15.67
Revenue Growth
★ N/A
N/A
52 Week Low
$88.41
$72.78
52 Week High
$212.71
$97.76

Technical Indicators

Market Signals
Indicator
AZN
WFC
Relative Strength Index (RSI) 61.27 50.13
Support Level $181.04 $83.38
Resistance Level $193.52 $86.17
Average True Range (ATR) 3.62 1.95
MACD -0.24 0.07
Stochastic Oscillator 66.48 27.00

Price Performance

Historical Comparison
AZN
WFC

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

About WFC Wells Fargo & Company

Wells Fargo is a premier, North American-focused banking titan that commands a $2.25 trillion balance sheet and the third-highest deposit market share in the United States. The bank uses a dense, expansive network of 4,079 branches to champion retail consumers and the middle market, where the firm has built a particularly strong reputation. Following the removal of its federal asset cap in 2025, the firm is set to deploy its legacy excess liquidity to expand each of its four segments: consumer & business lending, commercial banking, corporate & investment banking, and wealth & investment management.

Share on Social Networks: